These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1983413

  • 21. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A, Barbara L, Bianchi-Porro G, Blasi A, Canelli B, Cheli R, Dal Monte R, Dammann HG, Francavilla A, Hentschel E.
    Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581
    [Abstract] [Full Text] [Related]

  • 22. Prevention of NSAID-gastropathy.
    Ardizzone S, Bianchi Porro G.
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [Abstract] [Full Text] [Related]

  • 23. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
    Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
    [Abstract] [Full Text] [Related]

  • 24. [Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study].
    Ciaco A, Papi C, Capurso L.
    Minerva Gastroenterol Dietol; 1992 Jun; 38(3):153-9. PubMed ID: 1363719
    [Abstract] [Full Text] [Related]

  • 25. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F, Bargiggia S, Bollani S, Colombo E, Bianchi Porro G.
    Hepatogastroenterology; 1998 Jun; 45(22):990-3. PubMed ID: 9755995
    [Abstract] [Full Text] [Related]

  • 26. H2-blockers: how safe and how effective?
    Spiro HM.
    J Clin Gastroenterol; 1983 Jun; 5 Suppl 1():143-7. PubMed ID: 6140282
    [Abstract] [Full Text] [Related]

  • 27. Seasonal behaviour of healed duodenal ulcer.
    Gupta AK, Pal LS.
    J Indian Med Assoc; 1998 Apr; 96(4):106-8. PubMed ID: 9844330
    [Abstract] [Full Text] [Related]

  • 28. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P, Wong EC.
    J Gastroenterol Hepatol; 1989 Apr; 4 Suppl 2():75-81. PubMed ID: 2577478
    [Abstract] [Full Text] [Related]

  • 29. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR, Tankanow RM, Nostrant TT.
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [Abstract] [Full Text] [Related]

  • 30. Role of H2-receptor antagonists in the treatment of duodenitis.
    Laguzzi E, Blago MR, Girmania P, Sitar G.
    Tokai J Exp Clin Med; 1992 Jul; 17(2):63-6. PubMed ID: 1359681
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Action of famotidine and ranitidine on prostaglandin E2 (PGE2) content of fundic and duodenal mucosa in duodenal ulcer patients.
    Lezoche E, Vagni V, D'Alessandro MD, Mariani P, Carlei F, Lomanto D, Nardovino M, Martelli A, Speranza V.
    Drugs Exp Clin Res; 1987 Jul; 13(10):655-8. PubMed ID: 2892658
    [Abstract] [Full Text] [Related]

  • 33. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W.
    J Int Med Res; 1989 Jul; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [Abstract] [Full Text] [Related]

  • 34. High IgE serum levels and "peptic" ulcers: clinical and functional approach.
    De Lazzari F, Mancin O, Plebani M, Venturi C, Battaglia G, Vianello F, Galliani EA, Di Mario F, Naccarato R.
    Ital J Gastroenterol; 1994 Jul; 26(1):7-11. PubMed ID: 7912969
    [Abstract] [Full Text] [Related]

  • 35. Gastrin pathophysiology: antisecretory drugs.
    Delle Fave G, Annibale B, De Magistris L.
    Ital J Gastroenterol; 1990 Jul; 22 Suppl 2():32-5. PubMed ID: 1983415
    [Abstract] [Full Text] [Related]

  • 36. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
    Korman MG, Hansky J, Eaves ER, Schmidt GT.
    Gastroenterology; 1983 Oct; 85(4):871-4. PubMed ID: 6136450
    [Abstract] [Full Text] [Related]

  • 37. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC, Lee CL, Chan CC, Tu TC, Liao CC, Wu CH, Chen TK.
    Arch Intern Med; 2003 Sep 22; 163(17):2020-4. PubMed ID: 14504114
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
    Sevvel S, Ananthakrishnan N, Kate V.
    Trop Gastroenterol; 1996 Sep 22; 17(4):227-9. PubMed ID: 9094865
    [Abstract] [Full Text] [Related]

  • 40. [Currents aspects of H2 receptor antagonists in the treatment of ulcers].
    Debongnie JC.
    Acta Gastroenterol Belg; 1992 Sep 22; 55(5-6):415-22. PubMed ID: 1363166
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.